Ami

Ami Organics IPO

Ami Organics Limited is one of the leading research and development-driven manufacturers of specialty chemicals. The company manufactures different types of Advanced Pharmaceutical Intermediates and Active Pharmaceutical Ingredients (API) for New Chemical Entities, and materials for agrochemicals and fine chemicals.

The company has developed over 450 pharma intermediates across 17 key therapeutic areas i.e. anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant, and anti-coagulant. It supplies its products to more than 150 customers (including international customers) directly in India and in 25 countries overseas i.e. Europe, USA, China, Israel, Japan, Latin America, etc. Laurus Labs, Cadila Healthcare, Cipla Ltd are some of the domestic customers whereas Organike s.r.l.a. Socio Unico, Fermion Oly, Medichem S.A. and Midas Pharma GmbH are some of the international customers.

The company has three manufacturing facilities in Gujarat situated at Sachin, Ankleshwar & Jhagadia, with an aggregate installed capacity of 6,060 MTPA.

Strength of Ami Organics

  • One of the leading manufacturers of certain Pharma Intermediates i.e. Dolutegravir, Trazodone, Entacapone, Nintedanib, and Rivaroxaban.
  • Strong and diversified product portfolio with 450+ Pharma Intermediates across 17 therapeutic areas.
  • Extensive geographical presence and diversified customer base.
  • Strong R&D, sales, and marketing capabilities
  • Consistent financial performance track record.

Risk

Ami Organics IPO Details

IPO Opens on:  1 September 2021

IPO Closes on: 3 September 2021

Price Band:  Rs 603-610 per share

Bid Lot:  24 shares and in multiples of 24 shares

Minimum Investment: Rs 14,640

Maximum Investment: Rs 190,320

IPO Size: Rs 569.64 Cr

Fresh issue: Rs 200.00 Cr

Offer for Sale: Rs 369.64 Cr

Retail Allocation: 35%

Employees Discount: Rs 0 per share

Ami Organics IPO TimeLine

Finalisation of Allotment: 8 September 2021

Initiation of Refunds: 9 September 2021

Transfer of Shares to Demat Account: 13 September 2021

Listing At: NSE & BSE

Listing Date: 14 September 2021

Financial Performance of (in Crores) Ami Organics

FY2019 FY2020 FY2021
Total Revenue 238.9 242.5 342.0
Total Expense 203.8 207.7 270.3
Net Income 24.7 29.6 53.1
Net margin (%) 10.3 12.2 15.5

Ami Organics IPO Valuations

Face Value = Rs 10

Earnings Per Share (EPS) = Rs 17.14

PE Ratio = 35.2 – 35.6

Return on Net Worth (RONW) = 32.35%

Net Asset Value = 52.99 per share

Ami Organics Subscription Details as on 1 September 2021 till 11:00 am

Category Shares offered Subscription (no. of times)
Day 1 Day 2 Day 3

QIB

NII
Retail
Total

Grey Market Premium of Ami Organics IPO Day by Day

Grey market premium as on 30-08-2021 = Rs.45/Share

Grey market premium as on 29-08-2021 = Rs.55/Share

Grey market premium as on 28-08-2021 = Rs.55/Share

Grey market premium as on 27-08-2021 = Rs.50/Share

Grey market premium as on 26-08-2021 = Rs.0/Share

Grey market premium as on 25-08-2021 = Rs.0/Share

Reach out

Find us at the office

Exel- Frazzitta street no. 61, 44925 Kingston, Norfolk Island

Give us a ring

Jovanny Boeding
+23 274 947 142
Mon - Fri, 10:00-21:00

Tell us about you